1-1 of 1
Joelle Guilhot, MBci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pegylated Interferon Alpha-2a Therapy for Patients with High Risk Essential Thrombocytemia: a Retrospective Analysis on 59 Patients.On Behalf of the French Intergroup of Myeloproliferative Disorders (FIM)

Lydia Roy, MD, Jean Christophe Ianotto, MD, Joelle Guilhot, MBci, Emmanuel Raffoux, MD, Emmanuel Gyan, MD, PhD, Benoit de Renzis, MD, Laurence Legros, MD, Jean-François Viallard, MD-PhD, Françoise Boyer, MD, Cony Makhoul, MD, Franck E Nicolini, MD, PhD, Jean Gunecht, MD, Stephane Giraudier, MD-PhD
Journal: Blood
Blood (2010) 116 (21): 1974.
https://doi.org/10.1182/blood.V116.21.1974.1974
Published: 2010